Drugs Made In America Acquisition (DMIIR) Consolidated Net Income (2025)

Drugs Made In America Acquisition (DMIIR) reported Consolidated Net Income of $4.6 million for Q4 2025, up 10041.88% quarter-over-quarter from -$46158.0 in Q3 2025.

Drugs Made In America Acquisition (DMIIR) Consolidated Net Income (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 1 years of Consolidated Net Income data on file, last reported at $4.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 3.87 Mn
2 Berto Acquisition 312.16 Mn 312.16 Mn - 2.22 Mn
3 Centurion Acquisition 311.79 Mn 311.79 Mn - 2.52 Mn
4 Churchill Capital Corp IX 309.64 Mn 309.64 Mn - 1.49 Mn
5 WEN Acquisition 308.55 Mn 308.55 Mn - 2.75 Mn
6 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - -612,993.00
7 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - 2.17 Mn
8 Soulpower Acquisition 265.17 Mn 265.17 Mn - 2.95 Mn
9 BTC Development 263.21 Mn 263.21 Mn - 1.70 Mn
10 Drugs Made In America Acquisition - - - 4.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.59 Mn
Sep 30, 2025 -46,158.00